Patent Application for Hyaluronic Acid Production Stimulation
Summary
The USPTO has published a new patent application (US20260083656A1) filed by Alastin Skincare, Inc. The application details compositions and methods for stimulating intrinsic hyaluronic acid production to improve skin moisture and elasticity. This is a routine publication of a patent application.
What changed
This document is a publication of a new patent application, US20260083656A1, filed by Alastin Skincare, Inc. The application pertains to compositions and methods designed to stimulate the body's natural production of hyaluronic acid, with the stated aim of enhancing skin moisture and elasticity.
As this is a patent application publication, it does not impose new regulatory obligations or deadlines on regulated entities. However, it may be of interest to pharmaceutical and cosmetic companies involved in skincare research and development, particularly those focusing on anti-aging or skin hydration technologies. Compliance officers should note this as a development in the intellectual property landscape for skincare ingredients.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS RELATING TO STIMULATION OF HYALURONIC ACID
Application US20260083656A1 Kind: A1 Mar 26, 2026
Assignee
Alastin Skincare, Inc.
Inventors
Alan David Widgerow, John A. Garruto
Abstract
Compositions and methods for stimulating intrinsic hyaluronic acid production are provided herein. Compositions and methods for stimulating intrinsic hyaluronic acid production can improve skin moisture and elasticity.
CPC Classifications
A61K 8/64 A61K 8/35 A61K 8/553 A61K 8/735 A61K 8/9728 A61K 36/07 A61Q 19/00 A61K 2800/10 A61K 2800/78
Filing Date
2025-02-26
Application No.
19064198
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.